Every SEC Form 3/4/5 on record for this filer (CIK 1741836) — 5 issuers, 120 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| INO | INOVIO PHARMACEUTICALS, INC. | Director | 2021-05-17 → 2026-05-21 | 9 | — |
| NRIX | Nurix Therapeutics, Inc. | Director | 2025-11-10 → 2026-05-15 | 3 | — |
| BCYC | BICYCLE THERAPEUTICS PLC | Director | 2025-09-10 → 2026-01-06 | 3 | — |
| KRON | Kronos Bio, Inc. | Director | 2023-04-24 → 2025-06-20 | 5 | — |
| SGEN | Seagen Inc. | President, R&D & CMO · lapsed | 2018-05-31 → 2023-12-15 | 51 | −$36M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SGEN | 2023-09-21 | Sell | 71 | $206.50 | $14,662 | 116,677 |
| SGEN | 2023-08-31 | Sell | 4,029 | $206.97 | $833,882 | 111,768 |
| SGEN | 2023-08-29 | Sell | 1,016 | $206.00 | $209,296 | 115,797 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.
